| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1e96496a9949403e2af2ca913e65bfec |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-03
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-85
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-91
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-16043
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2810-6081 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-713
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-70596
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1075 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-107
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-705
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-713 |
| filingDate |
2016-09-28^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2020-04-21^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f249bf7b944cf1788c16ffb1ce93c10c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c24f8e03659f1c9ff3b9824a8f92939c |
| publicationDate |
2020-04-21^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-10624849-B2 |
| titleOfInvention |
Targeted extracellular vesicles comprising membrane proteins with engineered glycosylation sites |
| abstract |
Disclosed are extracellular vesicles comprising an engineered targeting protein for targeting the extracellular vesicles to target cells. The targeting protein is a fusion protein that includes a ligand, an engineered glycosylation site, and an exosome-targeting domain. Exemplary extracellular vesicles may include but are not limited to exosomes. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112410376-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112410376-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11753621-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2021163933-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2020390700-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2022169978-A1 |
| priorityDate |
2015-09-28^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |